Evaluation of Target Specificity of Antibacterial Agents Using Staphylococcus aureus ddlA Mutants and D-Cycloserine in a Silkworm Infection Model
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1
- 저널
- ANTIMICROBIAL AGENTS AND CHEMOTHERAPY53(9) · pp.4025 · 2009
- 피인용
- Web of Science 16
- JCR IF
- JCR 2008 4.716
- ISSN
- 0066-4804
저자
- 쿠로가와 겐지제1저자교신저자National Research Laboratory of Defense Proteins, College of Pharmacy, Pusan National University, South Korea
- Hamamoto, HiroshiLaboratory of Microbiology, Graduate School of Pharmaceutical Sciences, University of Tokyo, Japan
- Matsuo, MikiLaboratory of Microbiology, Graduate School of Pharmaceutical Sciences, University of Tokyo, Japan
- Nishida, SatoshiLaboratory of Microbiology, Graduate School of Pharmaceutical Sciences, University of Tokyo, Japan
- Yamane, NorikoDiscovery Research Laboratories, Shionogi and Co., Ltd., Japan
- 이복률National Research Laboratory of Defense Proteins, College of Pharmacy, Pusan National University, South Korea
- Murakami, KazuhisaDiscovery Research Laboratories, Shionogi and Co., Ltd., Japan
- Maki, HidekiDiscovery Research Laboratories, Shionogi and Co., Ltd., Japan
- Sekimizu, KazuhisaLaboratory of Microbiology, Graduate School of Pharmaceutical Sciences, University of Tokyo, Japan
초록
The availability of a silkworm larva infection model to evaluate the therapeutic effectiveness of antibiotics was examined. The 50% effective doses (ED50) of D-cycloserine against the Staphylococcus aureus ddlA mutant-mediated killing of larvae were remarkably lower than those against the parental strain-mediated killing of larvae. Changes in MICs and ED50 of other antibiotics were negligible, suggesting that these alterations are D-cycloserine selective. Therefore, this model is useful for selecting desired compounds based on their therapeutic effectiveness during antibiotic development.
식별자
- WoS UID
- 000270014200060



로그인
연구물 목록으로